Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
ConditionSystemic Lupus Erthematosus (SLE)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Diego
About this trial
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Eligibility criteria
Qualifiers
patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
patients who are on Cellcept or Myfortic for at least 3 months prior to screening
patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.
Disqualifiers
pregnant or lactating patients,
patients with food allergy
patients on antibiotics within 4 weeks of the screening
patients that change the SLE therapy during the length of the study (12 weeks).
Trial design
Treatments tested in this trial
- anti-inflammatory diet
Treatment groups
36 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov